CYTOKINES AND ANTICYTOKINES IN THE PATHOGENESIS OF SEPSIS

Acton, 1996, Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors, Arch Surg, 131, 1216, 10.1001/archsurg.1996.01430230098017

Aderka, 1989, IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells and in mice, J Immunol, 143, 3517, 10.4049/jimmunol.143.11.3517

Aderka, 1992, Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors, J Exp Med, 175, 323, 10.1084/jem.175.2.323

Bazzoni, 1996, The tumor necrosis factor ligand and receptor families, N Engl J Med, 334, 1717, 10.1056/NEJM199606273342607

Berg, 1995, Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance, J Clin Invest, 96, 2339, 10.1172/JCI118290

Beutler, 1985, Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin, Science, 229, 869, 10.1126/science.3895437

Boehm, 1997, Cellular responses to interferon-γ, Annu Rev Immunol, 15, 749, 10.1146/annurev.immunol.15.1.749

Bone, 1997, Sepsis: A new hypothesis for pathogenesis of the disease process, Chest, 112, 235, 10.1378/chest.112.1.235

Car, 1994, Interferon γ receptor deficient mice are resistant to endotoxic shock, J Exp Med, 179, 1437, 10.1084/jem.179.5.1437

Dalrymple, 1996, Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection, Infect Immun, 64, 3231, 10.1128/IAI.64.8.3231-3235.1996

Dehoux, 1994, Compartmentalized cytokine production within the human lung in unilateral pneumonia, Am J Respir Crit Care Med, 150, 710, 10.1164/ajrccm.150.3.8087341

Dinarello, 1996, Biologic basis for interleukin-1 in disease, Blood, 87, 2095, 10.1182/blood.V87.6.2095.bloodjournal8762095

Döcke, 1997, Monocyte deactivation in septic patients: Restoration by IFN-γ treatment, Nat Med, 3, 678, 10.1038/nm0697-678

Echtenacher, 1990, Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis, J Immunol, 145, 3762, 10.4049/jimmunol.145.11.3762

Fantuzzi, 1996, Effect of endotoxin in IL-1β-deficient mice, J Immunol, 157, 291, 10.4049/jimmunol.157.1.291

Fischer, 1992, Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia, J Clin Invest, 89, 1551, 10.1172/JCI115748

Fisher, 1996, Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein, N Engl J Med, 334, 1697, 10.1056/NEJM199606273342603

Fröhlich, 1997, Perioperative pattern of peritoneal interleukin 8, tumour necrosis factor-α, and granulocyte elastase release in human secondary peritonitis, Cytokine, 9, 288, 10.1006/cyto.1996.0166

Gérard, 1993, Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia, J Exp Med, 177, 547, 10.1084/jem.177.2.547

Glaccum, 1997, Phenotypic and functional characterization of mice that lack the type I receptor for IL-1, J Immunol, 159, 3364, 10.4049/jimmunol.159.7.3364

Greenberger, 1996, IL-12 gene therapy protects mice in lethal Klebsiella pneumonia, J Immunol, 157, 3006, 10.4049/jimmunol.157.7.3006

Hesse, 1988, Cytokine appearance in human endotoxemia and primate bacteremia, Surgery Gynecology and Obstetrics, 166, 147

Kishimoto, 1995, Interleukin-6 family of cytokines and gp130, Blood, 86, 1243, 10.1182/blood.V86.4.1243.bloodjournal8641243

Kopf, 1994, Impaired immune and acute-phase responses in interleukin-6-deficient mice, Nature, 368, 339, 10.1038/368339a0

Lowry, 1995, Measurement of Inflammatory Mediators in clinical sepsis, 86

Marchant, 1994, IL-10 controls IFN-γ and TNF production during experimental endotoxemia, Eur J Immunol, 24, 1167, 10.1002/eji.1830240524

Marchant, 1994, Interleukin-10 production during septicaemia, Lancet, 343, 707, 10.1016/S0140-6736(94)91584-9

Moore, 1993, Interleukin-10, Annu Rev Immunol, 11, 165, 10.1146/annurev.iy.11.040193.001121

Munoz, 1991, Dysregulation of in vitro cytokine production by monocytes during sepsis, J Clin Invest, 88, 1747, 10.1172/JCI115493

Ogilvie, 1996, IL-1β does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer, J Immunol, 156, 389, 10.4049/jimmunol.156.1.389

Ohlsson, 1990, Interleukin 1 receptor antagonist reduces mortality from endotoxin shock, Nature, 348, 550, 10.1038/348550a0

Okusawa, 1988, Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition, J Clin Invest, 81, 1162, 10.1172/JCI113431

Pajkrt, 1997, Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia; the effect of timing of rhIL-10 administration, J Immunol, 158, 3971, 10.4049/jimmunol.158.8.3971

Pajkrt, 1997, Interleukin 10 inhibits activation of coagulation and fibrinolysis during human endotoxemia, Blood, 89, 2701, 10.1182/blood.V89.8.2701

Pfeffer, 1993, Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection, Cell, 73, 457, 10.1016/0092-8674(93)90134-C

Romani, 1997, Interleukin-12 in infectious diseases, Clin Microbiol Rev, 10, 611, 10.1128/CMR.10.4.611

Rothe, 1993, Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes, Nature, 364, 798, 10.1038/364798a0

Silva, 1992, Role of interferon-γ in experimental gram-negative sepsis, J Infect Dis, 166, 331, 10.1093/infdis/166.2.331

Stouthard, 1996, Interleukin 6 stimulates coagulation, not fibrinolysis, in humans, Thromb Haemost, 76, 738, 10.1055/s-0038-1650653

Tilg, 1994, Interleukin-6 (IL-6) as an antiinflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55, Blood, 83, 113, 10.1182/blood.V83.1.113.113

Tracey, 1986, Shock and tissue injury induced by recombinant human cachectin, Science, 234, 470, 10.1126/science.3764421

Trinchieri, 1995, Interleukin-12 and interferon-γ, Do they always go together? Am J Pathol, 147, 1534

Van der Poll, 1990, Activation of coagulation after administration of tumor necrosis factor to normal subjects, N Engl J Med, 322, 1622, 10.1056/NEJM199006073222302

Van der Poll, 1992, Effects on leukocytes following injection of tumor necrosis factor into healthy humans, Blood, 79, 693, 10.1182/blood.V79.3.693.693

Van der Poll, 1994, Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees, J Exp Med, 179, 1253, 10.1084/jem.179.4.1253

Van der Poll, 1995, Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense?, Shock, 3, 1, 10.1097/00024382-199501000-00001

Van der Poll, 1995, Endogenous Mechanisms Regulating TNF and IL-1 during Sepsis, 385, 10.1007/978-3-642-79154-3_31

Van der Poll, 1996, Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin, J Infect Dis, 174, 1356, 10.1093/infdis/174.6.1356

Van der Poll, 1996, Interleukin-10 impairs host defense in murine pneumococcal pneumonia, J Infect Dis, 174, 994, 10.1093/infdis/174.5.994

Van der Poll, 1997, Passive immunization against tumor necrosis factor alpha impairs host defense during pneumococcal pneumonia, Am J Respir Crit Care Med, 155, 603, 10.1164/ajrccm.155.2.9032201

Van der Poll, 1997, Interleukin-6 gene deficient mice show impaired defense against streptococcal pneumonia, J Infect Dis, 176, 439, 10.1086/514062

Van Deuren, 1994, Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections, J Infect Dis, 169, 157, 10.1093/infdis/169.1.157

Van Zee, 1992, Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo, Proc Natl Acad Sci U S A, 89, 4845, 10.1073/pnas.89.11.4845

Van Zee, 1994, A human tumor necrosis factor (TNF) α mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon, J Exp Med, 179, 1185, 10.1084/jem.179.4.1185

Wysocka, 1995, Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice, Eur J Immunol, 25, 672, 10.1002/eji.1830250307

Zeni, 1997, Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment, Crit Care Med, 25, 1095, 10.1097/00003246-199707000-00001